<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04254003</url>
  </required_header>
  <id_info>
    <org_study_id>CLO870-C003</org_study_id>
    <nct_id>NCT04254003</nct_id>
  </id_info>
  <brief_title>Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses</brief_title>
  <official_title>Clinical Performance Evaluation of Two Daily Disposable Silicone Hydrogel Toric Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the rotational behavior of DT1 Toric contact lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single visit, non-dispense study where subjects will be exposed to the test and
      control lenses for approximately 1 hour each.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 5, 2020</start_date>
  <completion_date type="Actual">March 2, 2020</completion_date>
  <primary_completion_date type="Actual">March 2, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of DT1 toric lenses with axis orientation within ±30° from the intended axis, 10 min after lens insertion</measure>
    <time_frame>Day 1, 10 minutes after lens insertion, each product</time_frame>
    <description>A slit lamp will be used to observe axis orientation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Refractive Errors</condition>
  <arm_group>
    <arm_group_label>Test, then Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>DT1 Toric contact lenses worn first, followed by AO1DfA contact lenses, as randomized. Each product will be worn in both eyes for approximately 1 hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control, then Test</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>AO1DfA contact lenses worn first, followed by DT1 Toric contact lenses, as randomized. Each product will be worn in both eyes for approximately 1 hour.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DT1 Toric contact lenses</intervention_name>
    <description>Delefilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)</description>
    <arm_group_label>Control, then Test</arm_group_label>
    <arm_group_label>Test, then Control</arm_group_label>
    <other_name>Test</other_name>
    <other_name>DAILIES TOTAL1 for Astigmatism (DT1 Toric)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AO1DfA contact lenses</intervention_name>
    <description>Senofilcon A contact lenses for the optical correction of astigmatism in people with healthy eyes with or without refractive ametropia (myopia or hyperopia)</description>
    <arm_group_label>Control, then Test</arm_group_label>
    <arm_group_label>Test, then Control</arm_group_label>
    <other_name>Control</other_name>
    <other_name>Acuvue Oasys 1-Day for Astigmatism (AO1DfA)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current wearer of any commercial soft daily wear contact lens with at least 3 months
             of wearing experience with a minimum wearing time of 5 days per week and 8 hours per
             day.

          -  Requiring contact lens (manifest refraction) of a cylindrical power of -0.75 to -2.50
             diopter cylinder (DC).

          -  Best corrected distance visual acuity 20/25 or better Snellen in each eye (as
             determined by manifest refraction at screening).

          -  Willing to NOT use rewetting/lubricating drops at any time during the study. Other
             protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Any anterior segment infection, inflammation, or abnormality or disease (including
             systemic) that contraindicates contact lens wear, as determined by the Investigator.

          -  Any use of systemic or ocular medications for which contact lens wear could be
             contraindicated, as determined by the Investigator.

          -  History of refractive surgery or plan to have refractive surgery during the study or
             irregular cornea in either eye.

          -  Eye injury in either eye within 12 weeks immediately prior to enrollment for this
             trial.

        Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trial Lead, Vision Care</last_name>
    <role>Study Director</role>
    <affiliation>Alcon Research, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alcon Investigative Site CT-11</name>
      <address>
        <city>Maitland</city>
        <state>Florida</state>
        <zip>32751</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alcon Investigative Site CT-27</name>
      <address>
        <city>Eden Prairie</city>
        <state>Minnesota</state>
        <zip>55344</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 31, 2020</study_first_submitted>
  <study_first_submitted_qc>February 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 5, 2020</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>toric contact lens</keyword>
  <keyword>daily disposable</keyword>
  <keyword>silicone hydrogel contact lens</keyword>
  <keyword>axis orientation</keyword>
  <keyword>astigmatism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

